Breaking Down Biotech ETFs
December 08, 2015 at 16:00 PM EST
Biotech ETFs have thoroughly enjoyed the prolonged bull run in markets. The sector was having a banner year in 2015 before August pared returns across the board but, fueled by increased political attention to pricing, biotech was among the hardest hit. We recently caught up with Paul Yook of...